A bit OT, but why not attach it to a nice long thread?

Every time I read about Karl Rove and friends blowing $300 million on the election I just have to chuckle. That really is small change in the world of drug approval. Apparently it is cheaper to try to get someone elected POTUS than to attempt to get a new drug approved by the FDA.

Sometimes I think we loose sight of just how much money is being spent on Afrezza, and why the capital raise results in so much dilution. It is truly unreal, but, alas, it is reality.